Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways

Area of Science:

• Pulmonology
• Immunology
• Cell Biology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease with unknown causes and poor prognosis.
• Immunosuppressive treatments have proven ineffective, leading to the immune system being overlooked in IPF research.
• Recent research highlights the critical regulatory role of immune cells, particularly macrophages, in IPF.

Purpose of the Study:

• To review the current understanding of the role of macrophages in IPF.
• To discuss the regulatory mechanisms involving macrophages in IPF pathogenesis.
• To provide an update on the involvement of immune receptors, cytokines, metabolism, and epigenetics in macrophage function in IPF.

Main Methods:

• Systemic review of fundamental and translational scientific literature.
• Analysis of the regulatory roles of immune cells, focusing on macrophages.
• Discussion of various mechanisms including immune receptors, cytokines, metabolism, and epigenetics.

Main Results:

• Macrophages are crucial immune cells that significantly influence IPF initiation and progression.
• These cells produce growth factors and mediators that impact the disease.
• Multiple regulatory pathways, including immune signaling, metabolic reprogramming, and epigenetic modifications, are involved.

Conclusions:

• Macrophages play a central regulatory role in idiopathic pulmonary fibrosis.
• Understanding these macrophage-mediated mechanisms is vital for developing novel IPF therapies.
• Further research into immune receptors, cytokines, metabolism, and epigenetics in macrophages is warranted for IPF treatment strategies.